These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18690855)

  • 1. Immunomodulatory therapy associated to anti-parasite drugs as a way to prevent severe forms of malaria.
    Muniz-Junqueira MI
    Curr Clin Pharmacol; 2007 Jan; 2(1):59-73. PubMed ID: 18690855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule-based inhibition of MEK1/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes.
    Wu X; Dayanand KK; Thylur RP; Norbury CC; Gowda DC
    J Biol Chem; 2017 Aug; 292(33):13615-13634. PubMed ID: 28679535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe malaria: what's new on the pathogenesis front?
    Wassmer SC; Grau GE
    Int J Parasitol; 2017 Feb; 47(2-3):145-152. PubMed ID: 27670365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte rosetting in Plasmodium falciparum malaria--with special reference to the pathogenesis of cerebral malaria.
    Carlson J
    Scand J Infect Dis Suppl; 1993; 86():1-79. PubMed ID: 8493454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status.
    Duarte J; Deshpande P; Guiyedi V; Mécheri S; Fesel C; Cazenave PA; Mishra GC; Kombila M; Pied S
    Malar J; 2007 Jan; 6():1. PubMed ID: 17204149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
    Higgins SJ; Kain KC; Liles WC
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):803-19. PubMed ID: 21905788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria.
    Mimche PN; Taramelli D; Vivas L
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S10. PubMed ID: 21411011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on Recent Advances for the Treatment of Cerebral Malaria.
    Purohit D; Kumar S; Dutt R; Bhardwaj TR
    Mini Rev Med Chem; 2022; 22(12):1607-1618. PubMed ID: 34819002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of malaria.
    Clark IA; Schofield L
    Parasitol Today; 2000 Oct; 16(10):451-4. PubMed ID: 11006479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment.
    Newton CR; Krishna S
    Pharmacol Ther; 1998 Jul; 79(1):1-53. PubMed ID: 9719344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria blood-stage infection and its control by the immune system.
    Perlmann P; Troye-Blomberg M
    Folia Biol (Praha); 2000; 46(6):210-8. PubMed ID: 11140853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Along a TNF-paved road from dead parasites in red cells to cerebral malaria, and beyond.
    Clark IA
    Parasitology; 2009 Oct; 136(12):1457-68. PubMed ID: 19450376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled nitric oxide and cerebral malaria: basis of a strategy for buying time for pharmacotherapy.
    Bergmark B; Bergmark R; Beaudrap PD; Boum Y; Mwanga-Amumpaire J; Carroll R; Zapol W
    Pediatr Infect Dis J; 2012 Dec; 31(12):e250-4. PubMed ID: 22760538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive therapy for severe malaria: a review and critical appraisal.
    Varo R; Crowley VM; Sitoe A; Madrid L; Serghides L; Kain KC; Bassat Q
    Malar J; 2018 Jan; 17(1):47. PubMed ID: 29361945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.
    John CC; Kutamba E; Mugarura K; Opoka RO
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):997-1008. PubMed ID: 20818944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria: becoming more specific about non-specific immunity.
    Kwiatkowski D
    Curr Opin Immunol; 1992 Aug; 4(4):425-31. PubMed ID: 1388844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.
    Akanmori BD; Kurtzhals JA; Goka BQ; Adabayeri V; Ofori MF; Nkrumah FK; Behr C; Hviid L
    Eur Cytokine Netw; 2000 Mar; 11(1):113-8. PubMed ID: 10705308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.
    Tchinda VH; Tadem AD; Tako EA; Tene G; Fogako J; Nyonglema P; Sama G; Zhou A; Leke RG
    Acta Trop; 2007 Apr; 102(1):20-8. PubMed ID: 17397790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral malaria: what is known and what is on research.
    Gay F; Zougbédé S; N'dilimabaka N; Rebollo A; Mazier D; Moreno A
    Rev Neurol (Paris); 2012 Mar; 168(3):239-56. PubMed ID: 22386676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.